Vabicaserin (codenamed SCA-136) is an investigational antipsychotic and anorectic that was under development by Wyeth. As of 2010, it is no longer in clinical trials for the treatment of psychosis.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.